Emerald Clinical Trials Unveils New Identity
The new name reflects the company’s commitment to growth and transparency in clinical trials globally.
Emerald Clinical Trials, formerly known as George Clinical, proudly announces its rebranding effort, a change that embodies not just a new name but a renewed vision for clinical research. This transformation signals the organization’s dedication to delivering clarity and confidence in the clinical trial process
Reaffirming Commitment to Clinical Research
With over two decades of experience, Emerald Clinical Trials stands as a pivotal resource for clinical research organizations (CROs) worldwide. The name change is a strategic initiative aimed at highlighting the firm's established credentials as a dependable and adaptable CRO. Emerald effectively reduces global developmental risks through its extensive expertise and operational insights across various therapeutic areas.
Continuing Commitment to Key Therapeutic Areas
Emerald Clinical Trials emphasizes its role in pivotal areas such as Oncology and Cardio-Renal-Metabolic (CRM). The company is dedicated to implementing end-to-end services, focusing on innovative solutions that reshape clinical research practices worldwide. The new moniker reflects the company's mission to enhance healthcare and improve lives through committed research and dedicated client service.
Global Reach and Expertise
Emerald Clinical Trials operates in 42 countries directly and even more through partnerships, which ensures a broad reach capable of facilitating seamless execution of trials. This extensive network allows Emerald to serve a wide array of clients, ranging from emerging biotech firms to industry-leading pharmaceutical companies.
Enhancing Client Relationships
At the heart of Emerald's rebranding is a renewed commitment to cultivating strong relationships with clients built on trust and reliability. Their focus on customer-centricity creates long-lasting partnerships that yield measurable results. Their exemplary track record of repeat business and recognition through industry awards stands testament to their excellence in the field.
Voices from Within the Company
“For two decades, Emerald Clinical Trials has been at the forefront of delivering high-quality clinical research that merges global capabilities with personalized attention. We possess the sophistication of a large CRO with the customer focus of a smaller entity,” explains Mary Gunn, CEO of Emerald Clinical Trials. This balance empowers clients to navigate the complexities of clinical programs with confidence and clarity.
Dr. Daniel Tillett, CEO of Race Oncology, an esteemed partner of Emerald, highlights the importance of collaboration. “We aimed to work with a CRO offering tailored strategies for each trial, maximizing efficiency in timelines and resource allocation. Emerald excels in offering that flexibility, aligning seamlessly with our needs,” he shares.
About Emerald Clinical Trials
Operating globally, Emerald Clinical Trials supports over 100 biotech companies and is affiliated with six of the top ten pharmaceutical firms. Headquartered in Singapore, Emerald brings unparalleled operational expertise and scientific excellence to its comprehensive suite of clinical trial services. The organization delivers innovative solutions across all clinical phases, ensuring worldwide clients receive the support they require.
Frequently Asked Questions
What prompted the rebranding of George Clinical to Emerald Clinical Trials?
The rebranding reflects Emerald Clinical Trials' growth, vision, and commitment to enhancing global clinical research transparency.
What services does Emerald Clinical Trials offer?
Emerald Clinical Trials provides end-to-end clinical trial services across various therapeutic areas, focusing on innovative solutions and patient-centered approaches.
Where is Emerald Clinical Trials headquartered?
The company is headquartered in Singapore, where it operates with a focus on scientific excellence and operational expertise.
How does Emerald Clinical Trials support its clients?
The firm emphasizes strong, trust-based relationships, offering tailored solutions and dedicated support to navigate the complexities of clinical trials.
What therapeutic areas does Emerald specialize in?
Emerald Clinical Trials specializes in key areas including Oncology and Cardio-Renal-Metabolic (CRM) therapeutic sectors, aiming to advance research and improve patient outcomes.
